Podcasts about Pancreatic cancer

When does an entrepreneur make time? How can an entrepreneur work 27 hours a day? How hard (or easy) is work-life balance? On this week's episode, Shawn & George interview Tiffanie Kellog who today (if you're listening on the day of release) releases her FOURTH self-published book, The Entrepreneur's Guide to More Free Time.  Tiffanie is the Sock-it-to-'em Success Strategist!  Since 2005, Tiffanie has been revolutionizing entrepreneurs' paths, unlocking greater wealth, freedom, and joy! As the creator of “eTiffanies” — epiphanies inspired by Tiffanie — she is known for her signature socks (over 400 pairs!), a charming southern accent, and her unique ability to inspire and empower others. Whether delivering dynamic keynote presentations, training locally and globally (often virtually), writing her next book, or leading her More Abundant Entrepreneurs community, Tiffanie loves helping people create the life they desire. With a passion for blending fun and strategy, Tiffanie helps her clients focus on achieving their goals while loving the journey. Her secret to success? Loving what she does so much that no one can tell if she's working or playing! Are you ready to sock it to your challenges, make more money, save time, and have fun? This is Tiffanie's seventh appearance on the podcast: Episode 381 (Talking about the no spend challenge) Episode 332 (Making time to crush your debt) Episode 242 (More money through masterminds) Episode 146 (13 months a year) Episode 76 (Referrals for Life) Episode 48 (Knock your socks off Speaking) Now Tiffanie is working on time management, or priority management, and how you can avoid BSO (Bright Shiney Objects) in your day.  And rather than Work/Life balance, we focus on Harmony or being "Off Balance On Purpose." You can get your copy of Tiffanie's new book or her previous three books at www.TiffanieKellog.com. And, Tiffanie is giving all of our listeners a free gift by going to this link: https://moreabundantentrepreneurs.com/moretime  Let us know if you enjoy this episode and, if so, please share it with your friends! Or, you can support the show by visiting our Patreon page: https://www.patreon.com/crushingDebt   To contact George Curbelo, you can email him at GCFinancialCoach21@gmail.com or follow his Tiktok channel - https://www.tiktok.com/@curbelofinancialcoach   To contact Shawn Yesner, you can email him at Shawn@Yesnerlaw.com or visit www.YesnerLaw.com. And please consider a donation to Pancreatic Cancer research and education by joining Shawn's team at MY Legacy Striders: http://support.pancan.org/goto/MyLegacy2026   

TWiM explains studies that show that the oral bacterial and fungal microbiome are risk factors for pancreatic cancer, and the gut microbiome and pyruvate metabolism of older adults are a link between sleep quality and frailty. Hosts: Vincent Racaniello, Michael Schmidt, and Michele Swanson. Subscribe to TWiM (free) on Apple Podcasts, Spotify, Android, RSS, or by email. Become a patron of TWiM. Music used on TWiM is composed and performed by Ronald Jenkees and used with permission. Links for this episode Oral microbiome and pancreatic cancer risk (JAMA Oncol) 2025 Cancer Facts & Figures (ACS) Periodontal Disease: The Good, The Bad, and The Unknown (Front Cell Infect Micro) Socransky's disease complexes (Microorg) Microbiome, pyruvate metabolism, sleep quality, and frailty (Cell Rep) Pittsburgh Sleep Quality Index (pdf) How to score the sleep quality index (pdf) Take the TWiM Listener survey! Send your microbiology questions and comments (email or recorded audio) to twim@microbe.tv

In this episode of the Tough Girl Podcast, I'm joined by the incredible Julie Weiss — also known as The Marathon Goddess. Julie's story is one of resilience, healing, and purpose. After losing her father to pancreatic cancer, she set out on an extraordinary mission: to run 52 marathons in 52 weeks, raising awareness and funds for pancreatic cancer research along the way. Her journey captured hearts around the world — from the Today Show and O Magazine to countless finish lines across the US. But behind the medals and media attention is a woman who found strength, joy, and hope through running. Now in her fifties, Julie has completed over 118 marathons, raised more than $1 million for research, and continues to inspire others with her message that it's never too late to chase your dreams, honour your loved ones, and find purpose in every step. In this conversation, Julie opens up about:  How running helped her heal from grief and depression  The challenges and triumphs of running 52 marathons in 52 weeks  What it takes to stay motivated and injury-free through massive goals  Her empowering “7 C's to Defy Your Limits” — Create, Certainty, Connect, Commit, Consistent, Cause, and Courage Julie's story is a beautiful reminder that transformation begins with one small step — and that every mile can make a difference.  New episodes of the Tough Girl Podcast drop every Tuesday at 7 AM (UK time)! Make sure to subscribe so you never miss the inspiring journeys and incredible stories of tough women pushing boundaries.  Do you want to support the Tough Girl Mission to increase the amount of female role models in the media in the world of adventure and physical challenges? Support via Patreon! Join me in making a difference by signing up here: www.patreon.com/toughgirlpodcast.  Your support makes a difference.  Thank you x Show notes Who is Julie Living in Santa Monica,  California, USA Being known as the Marathon Goddess - Running 52 marathon in 52 weeks Raising over $1 million for charity  Being excited to share the wisdom she has leaned from running marathons Her childhood and early years  Being tall with long legs Starting running at 37 years Not being at athlete at school Taking a different path Becoming a mother at 18  Not doing a lot of exercise in her younger years  Feeling at a very low point in her life Going for that first run on the beach  Wanting to feel good Keeping on running  Coming off anti-depressants  Fitting running into her life and making it work for her Joining a running group LA Road Runners Connecting with other people  Training for a triathlon first  Running her first marathon in March 2008 How running makes her feel  Her relationship with her dad Raising funds for Hirshberg Foundation for Pancreatic Cancer Research Taking 10 years to raise the funds  Project Purple Deciding to run 52 marathons in 52 weeks The Marathon Guy Being determined  Feeling overwhelmed at the start of the goal The start and the different steps involved Reaching out to charities, speaking to her boss The power of having purpose  The physicality of the challenge Protein, stretching, foam rolling, strength training, rest, compression tights, physio  The standout marathons from the challenge  The Leadville Marathon and the challenges of running at altitude   The Lake Tahoe Marathon The New York Marathon in 2012 - being cancelled   Marathon proposal! Being coached by her husband Qualifying for the Boston Marathon Losing her dad 19th attempt of getting into Boston Marathon Making the decision to run 52 marathons in 52 weeks Not giving up  The mental side of the challenge The importance of creating a goal that is important to you The 7Cs - Create, Certainty, Connect, Commit, Consistent, Cause, Courage  Enjoying what you've accomplished Writing her book  BOOK: The Miles and Trials of a Marathon Goddess: 52 Weeks, 52 Marathons Advice for deciding what to do? The importance of fun Chasing speed and wanting to quality for Boston again Running during peri-menopause and menopause Struggling with the lack of sleep and dealing with a lack of iron Compassion Reaching her 100th Marathon at the LA Marathon  Needing to keep on going  Being supported by her friends The importance of enjoying the journey and finding the joy How to connect with Julie  Words by ― CS Lewis “You are never too old to set a new goal or to dream a new dream.”   Social Media Website: www.julie-weiss.com  Instagram: @marathongoddess  Facebook: @Julie-WeissMarathonGoddess  

What is the real reason 90% of businesses fail? What are some bookkeeping or CFO mistakes most business owners make that can tank your business? On this week's episode of The Crushing Debt Podcast, George and Shawn talk to Emily Handren, owner and founder of Besty Bookkeepers (www.BestyBookkeepers.com).  For over two decades, Emily has helped individuals and businesses improve their financial situations through banking, investing, lending, and insurance guidance. She has owned both life/health and P&C agencies, and has plenty of real-world stories about helping people reduce costs and increase their net worth. Emily recently wrote a book "The Real Reason 90% of Businesses Fail: 101 Bookkeeping and CFO Mistakes You Can't Afford to Make"  that hit #1 in three categories: Small Business Bookkeeping, Entrepreneurship Management, and Business Planning & Forecasting. It focuses on practical money management strategies for businesses that could tie perfectly into debt reduction discussions. Here's the link if you'd like to check it out: https://a.co/d/2JDV3So In this episode, we talk about: Fractional CFO Bookkeepers v. Accountants Tech stacking Financial Forecasting Some of the 101 Mistakes, like: Exponential growth without a plan or foundation Improperty business structure knowing your expenses and your numbers using an outdated accounting system not paying yourself. You can reach Emily at her website www.BestyBookkeepers.com or Emily@BestyBookkeepers.com. Make sure you take the "Need a Better Bookkeeper" quiz on her website! Let us know if you enjoy this episode and, if so, please share it with your friends! Or, you can support the show by visiting our Patreon page: https://www.patreon.com/crushingDebt   To contact George Curbelo, you can email him at GCFinancialCoach21@gmail.com or follow his Tiktok channel - https://www.tiktok.com/@curbelofinancialcoach   To contact Shawn Yesner, you can email him at Shawn@Yesnerlaw.com or visit www.YesnerLaw.com. And please consider a donation to Pancreatic Cancer research and education by joining Shawn's team at MY Legacy Striders: http://support.pancan.org/goto/MyLegacy2026 

Synthetic progestogens hike risk for brain tumors, natural progesterone safe; Healthy microbiome, good genes, clean lifestyle propel world's oldest woman to age 117; Can you take too much selenium? Cannabis extract scores vs. low back pain; Can vitamin K prevent breast calcifications? Are we making progress vs. pancreatic cancer? 

What is the test for discharging a student loan in bankruptcy? Is it even possible? Student loans are non-dischargeable, right? WRONG !! On this week's episode, Shawn is back solo again (we'll hear George back again for next week's episode) interviewing attorney Jeff Hakanson.  Jeff has been an attorney for thirty (30) years! He granduating with his J.D. from South Texas College of Law and has practiced bankruptcy for his entire career.  On November 17, 2022, the U.S. Department of Justice issued a memorandum on student loan discharges.  What normally fell under the Brunner case and a Totality of Circumstances argument has now been streamlined by the US DOJ to assist in discharging student loan debts under certain circumstances, some of which include: The borrower is over 65; The borrower has a disability; The borrower has been unemployed 5 of the last 10 years; The borrower has attempted repayment in good faith. Typically these discharge cases are started with the filing of an Adversary Proceeding (with no fee if related to Student Loans) and then the debtor / borrower and attorney complete a "litigation package" with certain "attestations."  If the DOJ agrees, then the student loans can be discharged, or maybe modified in some capacity. The memorandum was designed to allow borrowers more clarity on discharging federally backed student loans (not private loans). Let us know if you enjoy this episode and, if so, please share it with your friends! Or, you can support the show by visiting our Patreon page: https://www.patreon.com/crushingDebt   To contact George Curbelo, you can email him at GCFinancialCoach21@gmail.com or follow his Tiktok channel - https://www.tiktok.com/@curbelofinancialcoach   To contact Shawn Yesner, you can email him at Shawn@Yesnerlaw.com or visit www.YesnerLaw.com.   And please consider a donation to Pancreatic Cancer research and education by joining Shawn's team (reactivated for 2026) at MY Legacy Striders: http://support.pancan.org/goto/MyLegacy2026   

Pancreatic cancer is among the deadliest forms of cancer, and Pennsylvania has one of the nation’s highest rates. For families like the Crosbys of Cumberland County, the disease has left a lasting mark — one they hope can spark more awareness, early detection, and support. The beginning of the school year is an exciting time, but many children will fall behind academically, developmentally and socially because of undetected vision issues. That is the concern of the Pennsylvania Optometric Association, POA, and the reason state lawmakers are sponsoring the Children’s Vision Bill. It calls for optometrists and ophthalmologists to perform vision exams at milestone years for students: kindergarten, fourth and eighth grades. The National Parent Teacher Association has reported that more than 10 million children in the U.S. suffer from undetected vision problems that can hamper learning success. Identifying those students who have vision-related deficiencies early on and getting them an effective diagnosis and treatment will make a significant impact on their overall quality of life and future. Support WITF: https://www.witf.org/support/give-now/See omnystudio.com/listener for privacy information.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in the Pharma and Biotech world.## Immuneering's drug atebimetinib has shown promising results in doubling overall survival in pancreatic cancer patients after nine months. Truist analysts have deemed the results encouraging, although some unknowns remain in the data. Immuneering plans to initiate a registrational trial for atebimetinib later this year. ## In other news, Lilly has halted a mid-stage obesity study for strategic reasons, Harmony has failed a pivotal trial for fragile X syndrome, and the FDA has released guidance to streamline the development of cell and gene therapies. Overall, Immuneering's drug shows potential in improving survival rates for pancreatic cancer patients, with further trials planned for the future.

In this extremely motivational episode of the Project Purple Podcast, host Dino Verrelli speaks with Michael Kennedy of Vermont, a lawyer and avid runner whose 20 years on the roads and trails unexpectedly prepared him for the toughest marathon of his life: pancreatic cancer. Michael shares how his story began in 2023, a year packed with long runs, two marathons, and a 100‑mile relay. But when back pain crept in after the relay, he brushed it off as age or overtraining. But within weeks, his symptoms escalated: rapid weight loss, changes in digestion, and eventually, a scan soon confirmed what no runner expects to hear: a tumor was on his pancreas. He recounts how his diagnosis in October 2023 launched him into treatment with the same discipline he'd honed as an athlete. Michael reflects on the months of chemotherapy, the neuropathy that forced him to wear mittens just to grab milk from the fridge, and the exhausting stretch of radiation—all to make surgery possible. In June 2024, he underwent a Whipple procedure with an innovative addition he advocated to have: a cutting‑edge CIVASheet radiation implant that allowed him to avoid post‑surgery chemo. Michael also describes how, even through treatment, he kept running. Running became a lifeline: “It's not gonna take the things from me unless it beats 'em out of me,” he says. He explains how discovering Project Purple gave him something to look forward to: a goal of finishing a marathon in the same calendar year as his Whipple surgery. Just months after leaving the hospital, he crossed the finish line of a December marathon in Jacksonville wearing a Project Purple singlet, and has since completed other races with the organization. In this conversation, Mike opens up about scanxiety, hope, and the power of staying positive. He discusses how his runner's mindset and experience being a high school basketball coach have taught him that you can do hard things one step at a time, which helped him through chemo and into recovery. And he offers practical advice: know the symptoms, and when life hands you a challenge, focus on WIN: What's Important Now. Mike's story is one of three Ps: positivity, perseverance, and the unexpected ways our passions can prepare us for life's biggest battles. You can find Mike on Instagram at: http://instagram.com/mkennedyvt/ Subscribe to the Project Purple Podcast to hear more stories from the pancreatic cancer community. And, if you'd like to learn more about or donate to Project Purple's mission of a world without pancreatic cancer, please visit https://www.projectpurple.org/.

Evening Prayer (people with pancreatic cancer)  #prayer #pray #eveningprayer #jesus #god #holyspirit #aimingforjesus #healing #bible #love #peace #pancreaticcancerThank you for listening, our heart's prayer is for you and I to walk daily with Jesus, our joy and peace aimingforjesus.com YouTube Channel https://www.youtube.com/@aimingforjesus5346 Instagram https://www.instagram.com/aiming_for_jesus/ Threads https://www.threads.com/@aiming_for_jesus X https://x.com/AimingForJesus Tik Tok https://www.tiktok.com/@aiming.for.jesus

Pancreatic cancer is among the deadliest forms of cancer, and Pennsylvania has one of the nation’s highest rates. For families like the Crosbys of Cumberland County, the disease has left a lasting mark — one they hope can spark more awareness, early detection, and support.Support WITF: https://www.witf.org/support/give-now/See omnystudio.com/listener for privacy information.

Interview with Jiyoung Ahn, PhD, author of Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer. Hosted by Vivek Subbiah, MD. Related Content: Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer

Interview with Jiyoung Ahn, PhD, author of Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer. Hosted by Vivek Subbiah, MD. Related Content: Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer

Doctor's bills and medical costs are mounting quickly for Johnie Joe Nieto of Floresville. Recently diagnosed with pancreatic cancer, the rural mail carrier's life has suddenly become a round of medical appointments and treatments, with chemotherapy starting soon. To help him meet the rising costs associated with his diagnosis and treatment, his niece, Amanda Rangel, set up a GoFundMe, inviting friends and community members to help Nieto in his time of need. Her uncle isn't married and has no children, she said, so she's doing all she can to help him, including taking him to his many appointments. She also...Article Link

Immunotherapy is not usually effective against pancreatic cancer (PC), but a new study published in Oncotarget (Volume 16, 2025) highlights rare cases where it did help. These examples, though uncommon, may offer valuable insights for future treatment. Pancreatic Cancer and Immunotherapy Pancreatic cancer is often diagnosed at an advanced stage, which limits treatment options and contributes to its poor prognosis. While chemotherapy remains the standard treatment, it usually offers only modest benefits in terms of survival. Immunotherapy—an approach that activates the immune system to fight cancer—has been effective in other cancers but has shown limited success in PC. This is largely due to the tumor's ability to suppress immune responses and create an environment that protects it from attack. Currently, these drugs are only approved for a small subset of patients whose tumors have a specific genetic feature called high microsatellite instability (MSI-high), found in just 1 to 2 percent of cases. The Study: Pancreatic Cancer Immunotherapy Responders The study, titled “Exceptional responders to immunotherapy in pancreatic cancer: A multi-institutional case series of a rare occurrence,” was led by first author Kavin Sugumar and corresponding author Jordan M. Winter, from University Hospitals Seidman Cancer Center. The researchers examined medical records from 14 patients with pancreatic ductal adenocarcinoma (PDAC) who had responded unexpectedly well to immune checkpoint inhibitors—drugs that help reactivate immune cells to attack cancer. The drugs included PD-1 inhibitors such as pembrolizumab and nivolumab, CTLA-4 inhibitors like ipilimumab, and agents targeting tumor-associated macrophages. To find these rare cases, the research team contacted 471 oncologists from 91 major U.S. cancer centers between 2020 and 2021. Full blog - https://www.oncotarget.org/2025/09/11/immunotherapy-response-in-pancreatic-cancer-what-a-new-study-reveals/ Paper DOI - https://doi.org/10.18632/oncotarget.28739 Correspondence to - Jordan M. Winter - jordan.winter@UHHospitals.org Abstract video - https://www.youtube.com/watch?v=VeWTcuVmqgM Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28739 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, pancreatic adenocarcinoma, immunotherapy, exceptional responders, microsatellite instability, survival To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

In this episode of the Project Purple Podcast, host Dino Verrelli speaks with Carmen Stewart, a pancreatic cancer survivor from across the globe, calling in all the way from Johannesburg, South Africa. Her story is one of perseverance, clarity, and transformation in the face of staggering odds. Carmen opens up about her whirlwind diagnosis in 2020 at the height of the pandemic, which followed months of persistent pain, varying symptoms, and repeated misdiagnoses, from gastroenteritis and hepatitis. She talks about how she pushed for surgery before lockdown hit in her country, against her doctor's initial plan, and how she underwent a Whipple procedure alone, with no support system allowed into the hospital due to pandemic restrictions. She goes into detail about her surgery, saying her surgeon called it a “miracle,” as her tumor had been capped and fully contained, preventing the cancer from spreading. Carmen explains her recovery wasn't easy—it was complicated by sepsis, delays in chemotherapy, a contraction of COVID-19, and the emotional toll of isolation. Still, she forged ahead, adding that it was the help of natural therapies, the love of and from her daughters, and an unwavering will to survive that kept her going. Carmen speaks candidly about survivor's guilt and the reality of life after treatment, which changed drastically for her in many ways. Her perspective is grounded in realism: “If it comes back, I'll deal with it. But if I'm clear, that's great.” She discusses how her experience reshaped her life—from managing her health and finishing her degree, to letting go of fear and finding joy in the present. Her message is clear: trust your instincts, choose the right medical team, and don't ignore what your body is telling you. Tune in to hear Carmen's candid conversation about navigating illness during a global crisis, rebuilding after the trauma that comes with this disease, and finding meaning in survival. Subscribe to the Project Purple Podcast to hear more stories from the pancreatic cancer community. To learn more or donate to Project Purple's mission of a world without pancreatic cancer, please visit https://www.projectpurple.org/.

Honoring Lori: fighting pancreatic cancer with purpose Jennifer Peterson and Nicole Hawes are on the board of the Lori Peterson Cancer Foundation, which was created to honor the life and legacy of Lori Lynn Peterson, who courageously battled pancreatic cancer. Carrying forward her spirit, the organization is dedicated to advancing research, supporting treatment, and raising awareness for one of the toughest cancers to fight. The foundation has funded projects that bring hope, progress, and real impact for patients and families. They are turning loss into legacy and making a difference in the fight against pancreatic cancer.  

I have high LDL cholesterol and a '0' calcium score.  Why does my doctor insist I take a statin?How much vitamin D should I take?  Which product do you recommend?Some doctors assert omega-3s are proinflammatory.  What say you?Study: Magnesium intake may be beneficial in preventing pancreatic cancerDo you have any products to regrow hair?I have a calcium score, but prefer to avoid Lipitor.

Potato intake and diabetes risk.How much daily leucine is required to regain muscle?

In today's episode, we passed the mic to Tara E. Seery, MD, who moderated an OncLive Insights discussion on the future of the pancreatic cancer treatment paradigm. Rounding out the discussion with additional expert perspectives were Paul E. Oberstein, MD, and Priyadarshini Pathak, MBBS. Seery is a medical oncologist at the Hoag Family Cancer Institute in Newport Beach, California. Oberstein is an associate professor in the Department of Medicine at the New York University (NYU) Grossman School of Medicine; as well as the director of the Gastrointestinal Medical Oncology Program, the assistant director of the Pancreatic Cancer Center, and the service chief of the Gastrointestinal Medical Oncology Program at NYU Langone's Perlmutter Cancer Center. Pathak is an assistant in medicine at Massachusetts General Hospital and an instructor in medicine at Harvard Medical School in Boston.  In this exclusive conversation, Drs Seery, Oberstein, and Pathak highlighted key data from the phase 3 NAPOLI 3 trial (NCT04083235) of NALIRIFOX (liposomal irinotecan, 5-fluorouracil [5-FU], leucovorin, and oxaliplatin) vs nab-paclitaxel (Abraxane) and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma; the toxicity profiles of NALIRIFOX and FOLFIRINOX (leucovorin, 5-FU, irinotecan, and oxaliplatin); real-world data with these regimens, and more. 

Listen in as Zev A. Wainberg, MD; Paul E. Oberstein, MD; and Mark O'Hara, MD, discuss the evolving treatment landscape for metastatic pancreatic cancer, including:How patients often present with disease-related symptomsTreatment selection considerations for the first-line and second-line settingHow to approach palliative care discussions with patientsEmerging therapies that are showing promise in this settingPresentersPaul E. Oberstein, MDAssociate Professor of MedicineSection Chief, GI OncologyPerlmutter Cancer CenterNYU Langone HealthNew York, New YorkMark O'Hara, MDAssociate Professor of MedicineDivision of Hematology and OncologyUniversity of PennsylvaniaPhiladelphia, PennsylvaniaZev A. Wainberg, MDProfessor of Medicine and SurgeryCo-Director of GI OncologyDirector, Early Phase Clinical Research ProgramJonsson Comprehensive Cancer CenterUCLA School of MedicineLos Angeles, CaliforniaLink to full program: https://bit.ly/45NdBTx

Maria Fundora, Purple Pansies: Fighting Pancreatic Cancer (North Fulton Business Radio, Episode 898) Maria Fundora, founder of Purple Pansies and owner of Casa Nuova Italian Restaurant, joined host John Ray on North Fulton Business Radio to share her mission to fight pancreatic cancer. After losing her mother to the disease, Maria turned personal loss into […] The post Maria Fundora, Purple Pansies: Fighting Pancreatic Cancer appeared first on Business RadioX ®.

Maria Fundora, Purple Pansies: Fighting Pancreatic Cancer (North Fulton Business Radio, Episode 898) Maria Fundora, founder of Purple Pansies and owner of Casa Nuova Italian Restaurant, joined host John Ray on North Fulton Business Radio to share her mission to fight pancreatic cancer. After losing her mother to the disease, Maria turned personal loss into […]

Tamar Braxton wakes up in a pool of blood, missing memories, broken teeth, and a fractured nose. What on earth happened? We're getting right into the heart of this headline. Let's break down the real possibilities together: sudden health crisis or something more sinister?We'll also talk about Judge Frank Caprio, the “nicest judge in the world,” and his fight with pancreatic cancer. There are lessons here for all of us about warning signs and risks.Jason Momoa's surfing accident made him quit smoking overnight - not for his kids or his ex, but because he was face-to-face with danger. Let's talk about the moments that make people finally change their bad habits.Did you hear that Serena Williams shared the real reason for her recent weight loss? Let's talk about it! And don't miss our discussion on comedian Guy Torry's blood clot scare - would you know what to do? We'll explain what a pulmonary embolism is and the symptoms you can't afford to ignore.This podcast is intended to be informational only.  It is not a medical consultation, nor is it personalized medical advice.  For medical advice, please consult your physician.#HealthHappyLifePodcast #DrFrita #MedicalMondays #CelebrityHealthNews #MedicineInTheNewsHere are a few helpful resources to help on your journey to wellness:▶️ Subscribe so you will never miss a YouTube video.

This month, the Department of Health and Human Services terminated almost $500 million in mRNA vaccine development grants and contracts. While HHS has said that these cuts won't affect mRNA cancer research, some researchers have expressed concern about the impact on their ongoing work. In light of these developments, we're revisiting a conversation from February.A team at Memorial Sloan Kettering is developing an mRNA vaccine for pancreatic cancer, which is notoriously difficult to treat. A few years ago, the team embarked on a small trial to test the vaccine's safety. Sixteen patients with pancreatic cancer received it, and half of them had a strong immune response. A follow-up study found that in six of those patients, the cancer hadn't relapsed after three years.Host Flora Lichtman spoke to study author Vinod Balachandran about the work, which has not yet been affected by the cuts, according to Memorial Sloan Kettering.Guest: Dr. Vinod Balachandran is an associate attending surgeon and Director of The Olayan Center for Cancer Vaccines at Memorial Sloan Kettering in New York, New York.Transcripts for each segment will be available after the show airs on sciencefriday.com.  Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

Dr Bill Nelson and Dr Michael Pishvaian discuss the targeting of KRAS mutations in pancreatic cancer to develop new treatment options for a disease that has been historically difficult to care for.

Bill Perkins, founder of Top Fan Rivalry, a baseball-centered community organization and a pancreatic cancer survivor, speaks with host Dino Verrelli in this powerful episode of the Project Purple Podcast. Hailing from Laguna Beach in the OC, Bill's story is as candid as it is inspiring. He shares how a moment in early 2022, when his wife noticed he looked jaundiced, set off a whirlwind of tests that led to a shocking diagnosis. What doctors first believed was a harmless blockage turned out to be pancreatic cancer. Within weeks, Bill underwent a grueling Whipple procedure, followed by a slow recovery and seven months of intense chemotherapy. He describes the emotional toll of being just 46 years old and hearing words like “life expectancy,” the terrifying stretch when a misread scan made it seem like the cancer had returned, and the strength it took to face survivor's guilt even after being declared cancer-free. Through it all, Bill credits faith, humor, a mental commitment to never giving up, and his wife's unwavering support as his anchors. A lifelong baseball fan, he opens up about how MLB's Stand Up To Cancer tribute moves him to tears and why a Rocky quote—“It ain't about how hard you hit, it's about how hard you can get hit and keep moving forward”—became his mantra. Now, more than three years out from surgery, Bill is channeling his resilience into helping others. Partnering with Project Purple, he's walking the equivalent distance from Dodger Stadium to Yankee Stadium (2,791 miles!) to raise awareness and prove that “you can do hard things,” hoping his journey inspires anyone facing dark days. Bill's advice is simple but hard-earned: be patient, fight with your loved ones by your side, keep a positive attitude, and remember, “the sun always comes up the next day.” Tune in for an episode full of honesty, perspective, and hope as Bill reminds us what it means to get knocked down, get back up, and keep moving forward. To support Bill's fundraising efforts, visit https://donate.projectpurple.org/campaign/694042/donate. Subscribe to the Project Purple Podcast for more stories from the pancreatic cancer community. If you'd like to donate to Project Purple's mission of a world without pancreatic cancer, please visit www.projectpurple.org/.

In episode 92 of the Summits Podcast, co-hosts Vince Todd, Jr. and Daniel Abdallah are joined by Joyce Irwin, President/CEO of the Community Health Network Foundation. Tune in as Joyce shares the genetic testing that led to her double mastectomy, her pancreatic cancer diagnosis, and how she's giving back through her work at the Community Health Network Foundation.

You might remember Alicia Purdy's first interview quite a while ago...now she's back with some more incredible nudges from God.  She thought she was going this way; God said, "Nope!  You're going THAT way!"Scripture mentioned:Isaiah 51Ps 40:1-3Neh 8:10Ps 22:3Ps 16:11Isaiah 55:11Reach Out to Me:Website: www.dontignorethenudge.comPatreon: www.patreon.com/dontignorethenudgeIG: @dontignorethenudgepodcastPrivate FB group to WATCH interviews: www.dontignorethenudge.com/facebook__________________________________________________________________________________________Business/Personal Coaching with Cori:www.corifreeman.com(951) 923-2674Reach Out to Alicia Purdy:Book and Devotional Link: The Way of the Worshipper: https://thewayoftheworshipper.com/ (the books can be purchased here, and the devotional, journalism-style blog articles are all here as well) YouTube: Read the Bible in a Year: https://www.youtube.com/@thewayoftheworshipperMy brother's mission, "Heroes & Horses" https://heroesandhorses.org/Link to purchase "THEY" on hard copy or Kindle: https://www.amazon.com/THEY-Alicia-Purdy/dp/B0CR813N57?

In this new episode of Speaking of SurgOnc, Dr. Rick Greene discusses with Dr. David Seo recent and ongoing high-impact clinical trials that analyze the multidisciplinary treatment of pancreatic ductal adenocarcinoma, as reported in the article, "The Landmark Series: The Future of Pancreatic Cancer Clinical Trials.”

You might remember Alicia Purdy's first interview quite a while ago...now she's back with some more incredible nudges from God.  She thought she was going this way; God said, "Nope!  You're going THAT way!"Scripture mentioned:Isaiah 51Ps 40:1-3Neh 8:10Ps 22:3Ps 16:11Isaiah 55:11Reach Out to Me:Website: www.dontignorethenudge.comPatreon: www.patreon.com/dontignorethenudgeIG: @dontignorethenudgepodcastPrivate FB group to WATCH interviews: www.dontignorethenudge.com/facebook__________________________________________________________________________________________Business/Personal Coaching with Cori:www.corifreeman.com(951) 923-2674Reach Out to Alicia Purdy:Book and Devotional Link: The Way of the Worshipper: https://thewayoftheworshipper.com/ (the books can be purchased here, and the devotional, journalism-style blog articles are all here as well) YouTube: Read the Bible in a Year: https://www.youtube.com/@thewayoftheworshipperMy brother's mission, "Heroes & Horses" https://heroesandhorses.org/Link to purchase "THEY" on hard copy or Kindle: https://www.amazon.com/THEY-Alicia-Purdy/dp/B0CR813N57?

Nutritionist Leyla Muedin reveals the alarming increase in obesity-associated cancers in the United States over the past two decades. Highlighting findings from a recent study presented at the Endocrine Society's annual meeting, Leyla underscores the significant rise in cancer deaths linked to obesity, particularly among women, older adults, Native Americans, and Black Americans. She also explores the complex causes of obesity, including genetics, lifestyle, and environmental factors, and offers insights into effective weight management strategies. Additionally, Leyla examines the high rates of heart disease in various U.S. states, emphasizing the importance of lifestyle modifications and public health initiatives to combat cardiovascular diseases.

     Noelle Gatlin had to endure a lengthy, multi-step process, but she survived Stage II pancreatic cancer.  A visit to an emergency department revealed a mass near her pancreas. She was transferred to a hospital, where a second CT scan resulted in her diagnosis.  Her care team placed a duodenal stent in Noelle, then a bile duct stent.  She next underwent a 12-infusion chemotherapy regimen with folfirinox.  Then she was ready for a Whipple procedure, a pancreatic duodenectomy, which was a success.  Noelle says because she took care of herself before, during and after treatment, she believes she is now in better health than she was before her diagnosis.   In July 2022, Noelle began to experience symptoms associated with food poisoning.  At an urgent care, she was diagnosed with gastric reflux, but when stomach became distended, her husband urged her to go to an emergency department.  That's where a CT scan revealed a mass near her pancreas.  She was next transferred to a hospital.  Wanting very much to vomit, but unable to, with the aid of an NG tube, her stomach was pumped.  She underwent another CT scan, then an endoscopy, after which a doctor told her she had Stage II pancreatic cancer.    A duodenal stent was placed in her small intestine so that food could go around where her tumor had closed off her intestinal tract.  Noelle then had a bile duct stent placed from her liver.  Before she could undergo surgery, she went on a 12-infusion chemotherapy regimen with folfirinox.    Months later came the Whipple Procedure.  Hers was a pancreatic duodenectomy.  Her gallbladder, the top 20 percent of her pancreas and the first section of her small intestine was removed.   The surgery was a success, and soon Noelle Gatlin returned to her job as a special education teacher in Riverton, Utah.  She followed instructions from care team and already enjoyed an active lifestyle.  This is why she believes her health today is better than it was prior to her diagnosis.   Additional Resources:   The Pancreatic Action Network (PanCAN): https://www.pancan.org    

Dr. Joshua Kays, is a board-certified surgeon with additional training in Complex General Surgical Oncology. He specializes in the surgical treatment of liver, pancreas and bile duct disease.

In this episode of the Project Purple Podcast, host Dino Verrelli speaks with Lew Worthington, a former pastor and seminary professor turned author from Lansing, Michigan. He courageously shares his remarkable journey with Stage 4 pancreatic cancer, describing how a persistent side pain quickly turned into a life-altering diagnosis in 2020 that he was told gave him just months to live. Lew recounts to listeners the difficult road he had ahead of him, undergoing intensive chemotherapy, targeted radiation, and devastating side effects. He mentions that, despite the odds of survival, he reached remission, only to face a recurrence of cancer that tested his resolve and faith once again. Fortunately, Lew shares that his health is stable, and he stays active playing tennis two to three times a week. Despite the bleak statistics surrounding pancreatic cancer, Lew's resilience propelled him forward. His story goes far beyond the medical, exploring profound reflections on life, hope, mortality, and spirituality. He grapples with the “why” of suffering and shares how his faith evolved through moments of doubt and acceptance. Lew also talks about the importance of compassion, not just from loved ones, but from the wider community. He discusses his recent book, Unlikely Hope: My Journey From Dying to Living with Pancreatic Cancer, a thoughtful autobiography that chronicles not only his two-time battle with cancer, but also the meaning he discovered along the way, blending medical realities with philosophical and theological insights. Listen in on this moving conversation that offers not only a story of survival, but also encouragement to listeners to always cling to whatever hope they can find, all while advocating for improved early pancreatic cancer detection. Subscribe to the Project Purple Podcast to hear more stories from the pancreatic cancer community. Learn more about Lew on his website https://lewworthington.com/ and find his book on Amazon here https://www.amazon.com/Unlikely-Hope-Journey-Living-Pancreatic/dp/B0F896HY38. If you'd like to donate to Project Purple's mission of a world without pancreatic cancer, please visit www.projectpurple.org/. To learn more about Project Purple, visit www.projectpurple.org/ or follow us on social media at these links: www.facebook.com/Run4ProjectPurple www.instagram.com/projectpurple/ twitter.com/Run4Purple www.youtube.com/channel/UCgA8nVhUY6_MLj5z3rnDQZQ

BUFFALO, NY – July 24, 2025 – A new #casereport was #published in Volume 16 of Oncotarget on July 23, 2025, titled “Extracorporeal blood filtration leading to tumor growth arrest and reduced analgesic requirements in Stage IV poorly differentiated pancreatic adenocarcinoma: A case report.” In this report, Susanna Ulahannan from the University of Oklahoma Health Sciences Center and colleagues describe the use of extracorporeal blood filtration in a patient with metastatic pancreatic cancer. The patient experienced clinical improvement, reduced pain, and no signs of new tumor growth over 12 months of follow-up. Metastatic pancreatic cancer is difficult to treat and is often diagnosed at an advanced stage. In this case, a 51-year-old woman with stage IV poorly differentiated adenocarcinoma chose not to undergo standard chemotherapy. Instead, she received extracorporeal blood filtration with the Seraph® 100 device, which is designed to remove circulating tumor cells (CTCs) from the bloodstream. CTCs are thought to contribute to the spread of cancer to other organs. “Circulating tumor cells (CTC's) are tumor cells that are shed from the primary tumor and travel via blood or lymphatic system to form micro metastases in distant organs under a suitable environment.“ The patient received between nine and twelve treatments over the course of a year. These treatments were performed both abroad, where the device is approved for this use, and under a clinical protocol in the United States. Medical imaging showed that her disease remained stable, with no new metastases detected. She also reported improvements in appetite, energy levels, and pain control. Her opioid use was reduced by 90%. Blood samples confirmed a drop in CTC levels after treatment. This observation supports the idea that removing CTCs might help limit cancer progression in some patients. However, given that this is a single case report, larger clinical studies are needed to evaluate the effectiveness of this approach. The mechanism behind the patient's pain relief is not fully understood. Authors suggest that it may be related to the reduction of tumor cells or inflammatory molecules in the blood. Researchers noted that pro-inflammatory cytokines, known to influence pain, could also have been affected by the filtration process. This is the first documented case of stable disease and reduced symptoms following CTC filtration in advanced pancreatic cancer. While these findings should not be generalized, they highlight an approach outside standard protocols that should be further explored in clinical research. Future studies will be needed to determine whether this method can contribute to symptom management or disease control in other patients with metastatic pancreatic cancer. DOI - https://doi.org/10.18632/oncotarget.28756 Correspondence to - Susanna Ulahannan - susanna-ulahannan@ouhsc.edu Video short - https://www.youtube.com/watch?v=dro6iUGDrVQ Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28756 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, extracorporeal blood filtration, circulating tumor cells, metastatic pancreatic cancer, seraph 100, OncoBind To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

Metastatic pancreatic cancer remains one of the deadliest cancers, but a new approach is taking shape - and it's showing promise in early clinical studies. In this episode, Dan Schmitt, President and CEO of Actuate Therapeutics, shares how elraglusib, an investigational targeted therapy, may provide a new option for patients with metastatic pancreatic cancer. We explore the urgent unmet need and why Dan thinks this could be a turning point for one of oncology's toughest challenges.

“I think that's what I would define pancreatic cancer as: never, ever give up.” In this powerful episode of the Project Purple Podcast, host Dino Verrelli speaks with Kelianne O'Shea, a 29-year-old from Cape May, New Jersey, who was diagnosed with stage four pancreatic cancer just one year ago. Now on maintenance chemo and marking a full year of what she calls “surviving pancreatic cancer,” Kelianne opens up about the physical and emotional rollercoaster of facing a devastating diagnosis at just 28 years old. She shares the story of her sudden symptoms and the ER visit that changed her life. Doctors initially gave her just months to live. But after a year of aggressive chemotherapy, her tumor has shrunk in half, and her medical team is hopeful. Kelianne reflects on how she navigated major life milestones, including getting married and going on her honeymoon, while undergoing treatment. Her story is one of strength, acceptance, and emotional honesty. She speaks candidly about the harm of toxic positivity, emphasizing the importance of allowing cancer patients to feel and express their emotions freely. “You don't always have to be positive,” she says. “Sometimes, you just want to be sad, and that's okay.” Now, Kelianne is sharing her journey publicly, using social media to educate others and connect with fellow survivors. From finding a cancer therapist to building a strong support system, her insights are heartfelt and grounded in experience. “This journey isn't linear,” she reminds listeners. Kelianne's story is a testament to perseverance and the healing power of connection. You can find her on Instagram https://www.instagram.com/keliannefield9/. Subscribe to the Project Purple Podcast for more powerful stories from the pancreatic cancer community. If you'd like to donate to Project Purple's mission of a world without pancreatic cancer, please visit https://www.projectpurple.org/. To learn more about Project Purple, visit https://www.projectpurple.org/ or follow us on social media at these links: https://www.facebook.com/Run4ProjectPurple https://www.instagram.com/projectpurple/ https://twitter.com/Run4Purple https://www.youtube.com/channel/UCgA8nVhUY6_MLj5z3rnDQZQ

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ANG865. CME/MOC/AAPA/IPCE credit will be available until June 29, 2026.Treatment Planning Made CLEAR in Neuroendocrine Tumors & Pancreatic Cancer: Personalized Integration of Validated & Emerging Therapies In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Let's Win, an affiliate of the Lustgarten Foundation, and Neuroendocrine Cancer Awareness Network. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by medical education grants from Exelixis, Inc., Ipsen Biopharmaceuticals, Inc., and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ANG865. CME/MOC/AAPA/IPCE credit will be available until June 29, 2026.Treatment Planning Made CLEAR in Neuroendocrine Tumors & Pancreatic Cancer: Personalized Integration of Validated & Emerging Therapies In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Let's Win, an affiliate of the Lustgarten Foundation, and Neuroendocrine Cancer Awareness Network. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by medical education grants from Exelixis, Inc., Ipsen Biopharmaceuticals, Inc., and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ANG865. CME/MOC/AAPA/IPCE credit will be available until June 29, 2026.Treatment Planning Made CLEAR in Neuroendocrine Tumors & Pancreatic Cancer: Personalized Integration of Validated & Emerging Therapies In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Let's Win, an affiliate of the Lustgarten Foundation, and Neuroendocrine Cancer Awareness Network. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by medical education grants from Exelixis, Inc., Ipsen Biopharmaceuticals, Inc., and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ANG865. CME/MOC/AAPA/IPCE credit will be available until June 29, 2026.Treatment Planning Made CLEAR in Neuroendocrine Tumors & Pancreatic Cancer: Personalized Integration of Validated & Emerging Therapies In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Let's Win, an affiliate of the Lustgarten Foundation, and Neuroendocrine Cancer Awareness Network. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by medical education grants from Exelixis, Inc., Ipsen Biopharmaceuticals, Inc., and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ANG865. CME/MOC/AAPA/IPCE credit will be available until June 29, 2026.Treatment Planning Made CLEAR in Neuroendocrine Tumors & Pancreatic Cancer: Personalized Integration of Validated & Emerging Therapies In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Let's Win, an affiliate of the Lustgarten Foundation, and Neuroendocrine Cancer Awareness Network. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by medical education grants from Exelixis, Inc., Ipsen Biopharmaceuticals, Inc., and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

Send us a textIn this episode of WTR Small-Cap x Healthcare Spotlight crossover episode, we are joined by Lisata Therapeutics' (NASDAQ: LSTA) CEO David Mazzo, PhD and Chief Medical Officer Kristen Buck, MD to talk about, Certepetide, the company's novel solid tumor targeting and penetration technology with tumor microenvironment modifying properties.  We also dive into the recently reported positive preliminary results from Lisata's lead program (Ascend), a Phase 2b study investigating Certepetide for metastatic pancreatic ductal adenocarcinoma (the most common and aggressive form of pancreatic cancer), Lisata's partnerships, and upcoming milestones.  

Today's guest is Dr. Rachel Orgel, a passionate educator with a lifelong commitment to student success. Diagnosed with a rare form of pancreatic cancer at age 13, Rachel would endure two recurrences and several surgeries in her teens and early 20s before an experimental procedure changed the game.We talk about childhood cancer, spending weeks or months in the hospital at a time, PTSD that still affects her today, the importance of humor, what led her to write her children's book, and so much more. Resources:Rachel's LinkedIn: https://www.linkedin.com/in/rachel-orgel-66a6b914/Rachel's Book on Amazon: But Is It The Bad Kind?Rachel's email: rachelorgelauthor@gmail.comFollow:Follow me: https://www.instagram.com/melissagrosboll/My website: https://melissagrosboll.comEmail me: drmelissagrosboll@gmail.com

Alex Berenson ReportsJapanese researchers published the finding last month; survival rates for pancreatic cancer have DECREASED at their hospital since the jabs were rolled out.Men who received three or more mRNA Covid shots died much more quickly of pancreatic cancer than those who did not, Japanese researchers have found.Intro song is '⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bring Me Down⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠'⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Buy Me a Coffee⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Slippery Slope Spotify⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠J Fallon Spotify⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Slippery Slope Apple Podcasts⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Slippery Slope YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠#jfallonmusic#theslipperyslopepodcast

Joyce discusses the Texas floods, What was the issue? Mother nature or lack of early warning systems? She also talks about the heroes. Japanese scientist link pancreatic cancer survival decline to the COVID-19 vaccine in certain cases. Elon Musk says he wants to start a third political party in the US, The FBI claims there was never an Epstein list, and ICE agents are being assaulted and the media seems to supports it.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I'm a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. In this episode, Dr. Warrick Bishop, a cardiologist and CEO of the Healthy Heart Network, discusses various health topics aimed at improving heart health and overall well-being. He emphasizes the importance of salt reduction, highlighting that the World Health Organization recommends consuming less than one teaspoon of salt daily. Research indicates that potassium-based salt substitutes can significantly reduce stroke and death risks. The podcast also covers bone health, clarifying that vitamin E may not be beneficial for bone density, while vitamins D and K2 are suggested for better bone and vascular health.

“Vax to the Future: Cancer Immunity Revolution

AGNTCY - Unlock agents at scale with an open Internet of Agents. Visit https://agntcy.org/ and add your support. What if your blood could reveal the future of your health - years before symptoms ever appear? In this episode of Eye on AI, Craig Smith sits down with Ash Anwar, co-founder of Molecular You, to explore how AI and advanced biomarker analysis are transforming how we detect and prevent disease.  From a real-life case where stage 1 pancreatic cancer was caught early, to the science behind tracking 250+ dynamic biomarkers, Ash breaks down how Molecular You is shifting healthcare from reactive treatment to proactive longevity.  They dive into the limitations of genetic testing, the power of machine learning models trained on clinical data, and how personalized action plans are helping individuals take control of their health in real time.  If you're curious about the intersection of AI, diagnostics, and the future of preventive medicine—this is a conversation you won't want to miss. Stay Updated: Craig Smith on X: https://x.com/craigss Eye on A.I. on X: https://x.com/EyeOn_AI (00:00) How AI Can Predict Disease Before It Happens   (02:02) Meet Ash Anwar: From Scientist to Health Tech Leader   (06:31) What Is Molecular You and How It Works   (09:43) Why Biomarker Tracking Over Time Is a Game-Changer   (15:46) How Molecular You Detected Stage 1 Pancreatic Cancer   (23:15) Biomarkers vs Genetics: What Really Matters   (28:11) The AI Models Behind Early Disease Detection   (32:37) How the Product Works for Clinics and Consumers   (35:05) Who They Compete With and What Makes Them Different   (37:34) Research vs Product: The Cancer Risk Challenge   (43:43) How Often Should You Get Tested?